文献速递关节外科

地塞米松对2型糖尿病患者全关节置换术后血糖的影响

The Effect of Dexamethasone on Postoperative Blood Glucose in Patients With Type 2 Diabetes Mellitus Undergoing Total Joint Arthroplasty.
PubMed 文献 · J Arthroplasty · 2019-10-31

一项回顾性研究纳入285例2型糖尿病患者,评估术前静脉注射8 mg地塞米松对全关节置换术后血糖和胰岛素需求的影响。结果显示地塞米松与术后最大血糖无关,但显著升高术后初始血糖并增加术后第0天天冬胰岛素需求;术前糖化血红蛋白与术后血糖控制关联最强。

要点

  • 术前地塞米松不增加术后最大血糖,但升高术后初始血糖。
  • 地塞米松增加术后第0天天冬胰岛素需求。
  • 术前糖化血红蛋白是术后血糖控制的最强预测因素。

核心结论

  • 术前地塞米松与2型糖尿病患者全关节置换术后初始血糖升高和术后第0天胰岛素需求增加相关,但对血糖控制的总体影响可能不抵消围手术期糖皮质激素的已知临床获益。

研究设计与样本

  • 回顾性研究纳入2010至2015年接受全关节置换术的2型糖尿病患者285例,比较术前接受与未接受8 mg静脉地塞米松患者的基线特征,采用 logistic 回归分析术后血糖和胰岛素需求。

主要发现

  • 地塞米松给药与术后最大血糖无显著相关(P = .78)。
  • 静脉地塞米松给药后术后初始血糖显著更高(P < .01)。
  • 地塞米松给药与术后第0天天冬胰岛素需求增加相关(P = .04)。
  • 术前糖化血红蛋白与术后血糖控制关联最强。

临床怎么用

  • 对2型糖尿病患者全关节置换术前使用地塞米松时,应关注术后初始血糖和胰岛素需求增加。
  • 术前糖化血红蛋白可用于识别术后血糖控制风险较高的患者。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Perioperative glucocorticoids are routinely administered to patients undergoing total joint arthroplasty (TJA) to decrease postoperative pain and nausea. However, there is concern regarding the effects of glucocorticoids on perioperative glucose control in diabetes. The goal of this study is to determine if administration of preoperative dexamethasone to diabetic patients is significantly associated with hyperglycemia and increased insulin requirements in the immediate postoperative period after TJA and to identify risk factors for postoperative hyperglycemia immediately after TJA. METHODS: A retrospective review of type 2 diabetic patients undergoing TJA from 2010 to 2015 (n = 285) was undertaken to evaluate the effect of dexamethasone on postoperative glucose control. Preoperative baseline characteristics were compared between patients who did and did not receive 8 mg of intravenous dexamethasone preoperatively. Postoperative glucose and insulin requirements were evaluated with respect to dexamethasone dosing. Statistical analysis was performed using logistic regression models. RESULTS: Dexamethasone administration did not correlate with the maximum postoperative blood glucose (P = .78). There was a significantly higher initial postoperative blood glucose after intravenous dexamethasone administration (P < .01). Dexamethasone administration was associated with increased aspart insulin requirements on postoperative day 0 (P = .04). However, preoperative hemoglobin A1c was most strongly associated with postoperative glucose control. CONCLUSION: Preoperative dexamethasone administration to diabetic patients was associated with an initial increase in blood glucose and increased insulin requirement on postoperative day 0. Yet the observed effect on glucose control in diabetic patients may not outweigh the known clinical benefits of perioperative glucocorticoids.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Allen DC, Jedrzynski NA, Michelson JD, et al. The Effect of Dexamethasone on Postoperative Blood Glucose in Patients With Type 2 Diabetes Mellitus Undergoing Total Joint Arthroplasty. J Arthroplasty. 2019. PMID: 31761675. doi:10.1016/j.arth.2019.10.030

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。